Vis enkel innførsel

dc.contributor.authorAlbert, Michael Anb_NO
dc.contributor.authorFretheim, Atlenb_NO
dc.contributor.authorMaïga, Diadiénb_NO
dc.date.accessioned2008-10-27T08:44:37Znb_NO
dc.date.accessioned2016-02-08T14:19:29Z
dc.date.available2008-10-27T08:44:37Znb_NO
dc.date.available2016-02-08T14:19:29Z
dc.date.issued2007-03-05nb_NO
dc.identifier.citationHealth research policy and systems 2007, 5:2en
dc.identifier.issn1478-4505nb_NO
dc.identifier.urihttp://hdl.handle.net/11250/2377806
dc.description.abstractBACKGROUND: Research findings are increasingly being recognized as an important input in the formation of health policy. There is concern that research findings are not being utilized by health policy-makers to the extent that they could be. The factors influencing the utilization of various types of research by health policy-makers are beginning to emerge in the literature, however there is still little known about these factors in developing countries. The object of this study was to explore these factors by examining the policy-making process for a pharmaceutical policy common in developing countries; an essential medicines list. METHODS: A study of the selection and updating of Mali's national essential medicines list was undertaken using qualitative methods. In-depth semi-structured interviews and a natural group discussion were held with national policy-makers, most specifically members of the national commission that selects and updates the country's list. The resulting text was analyzed using a phenomenological approach. A document analysis was also performed. RESULTS: Several factors emerged from the textual data that appear to be influencing the utilization of health research findings for these policy-makers. These factors include: access to information, relevance of the research, use of research perceived as a time consuming process, trust in the research, authority of those who presented their view, competency in research methods, priority of research in the policy process, and accountability. CONCLUSION: Improving the transfer of research to policy will require effort on the part of researchers, policy-makers, and third parties. This will include: collaboration between researchers and policy-makers, increased production and dissemination of relevant and useful research, and continued and improved technical support from networks and multi-national organizations. Policy-makers from developing countries will then be better equipped to make informed decisions concerning their health policy issues.en
dc.language.isoengen
dc.publisherBioMed Centralen
dc.relation.urihttp://www.health-policy-systems.com/content/5/1/2en
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Helsetjeneste- og helseadministrasjonsforskning: 806en
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801en
dc.subject.meshEvidence-Based Medicineen
dc.subject.meshHealth Services Researchen
dc.subject.meshHealth Knowledge, Attitudes, Practiceen
dc.subject.meshPolicy Makingen
dc.titleFactors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines.en
dc.typeJournal articleen
dc.typePeer revieweden
dc.source.journalHealth research policy and systems / BioMed Centralen
dc.identifier.doi10.1186/1478-4505-5-2nb_NO
dc.identifier.pmid17338810nb_NO
dc.contributor.departmentDepartment of General Practice and Community Medicine, University of Oslo, P.O. Box 1130, Blindern, N-0318, Oslo, Norway. michael.a.albert@gmail.comen


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel